ASP Isotopes (NASDAQ:ASPI) Stock Price Down 7% – Should You Sell?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) were down 7% during trading on Monday . The company traded as low as $7.69 and last traded at $7.8830. Approximately 1,956,681 shares were traded during trading, a decline of 69% from the average daily volume of 6,384,147 shares. The stock had previously closed at $8.48.

Wall Street Analyst Weigh In

ASPI has been the subject of a number of recent research reports. Cantor Fitzgerald began coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an “overweight” rating and a $13.00 price objective for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, December 29th. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Monday, November 24th. Finally, Loop Capital set a $15.00 price objective on ASP Isotopes in a research note on Monday, October 27th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $13.00.

ASP Isotopes Stock Performance

The company has a market capitalization of $830.30 million, a P/E ratio of -5.76 and a beta of 3.47. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The business’s fifty day simple moving average is $6.43 and its 200-day simple moving average is $8.44.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). The firm had revenue of $4.89 million for the quarter, compared to analysts’ expectations of $2.25 million. ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. As a group, equities analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, Chairman Paul Elliot Mann sold 162,153 shares of the stock in a transaction on Monday, December 1st. The shares were sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the transaction, the chairman owned 7,759,538 shares in the company, valued at $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Heather Kiessling sold 80,000 shares of ASP Isotopes stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total transaction of $464,000.00. Following the completion of the transaction, the chief financial officer directly owned 732,500 shares of the company’s stock, valued at $4,248,500. The trade was a 9.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 505,591 shares of company stock valued at $3,233,245 in the last ninety days. Corporate insiders own 14.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Rovida Advisors Inc. bought a new stake in ASP Isotopes during the second quarter worth approximately $16,148,000. Rovida Investment Management Ltd boosted its holdings in shares of ASP Isotopes by 528.6% in the 2nd quarter. Rovida Investment Management Ltd now owns 2,200,000 shares of the company’s stock worth $16,148,000 after purchasing an additional 1,850,000 shares during the period. Marshall Wace LLP increased its position in shares of ASP Isotopes by 3,669.1% during the 3rd quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock valued at $12,305,000 after purchasing an additional 1,245,184 shares during the last quarter. Vanguard Group Inc. increased its position in shares of ASP Isotopes by 37.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after purchasing an additional 1,241,024 shares during the last quarter. Finally, Jump Financial LLC purchased a new position in ASP Isotopes during the third quarter worth $8,990,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.